Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...
Bitcoin hits $50,000 milestone as investors celebrate positive factors, including surge in ETF inflows and upcoming halving. However, Solana network ...